Development of Robust Evaluation of T Cell Subsets with T-Cell Activation In a 3D Tumor–PBMC Co-Culture Model Enables Reliable Phenotyping and Cytotoxicity Assessment
Click to Download
Ready to scope your next preclinical study?
Talk to a study director about TumorGraft models, dosing strategy, and timelines for your program.
